Bay Rivers Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-395
Closed -$205K 85
2024
Q3
$205K Hold
395
0.1% 81
2024
Q2
$214K Hold
395
0.11% 72
2024
Q1
$205K Buy
+395
New +$196K 0.11% 76
2023
Q1
Sell
-423
Closed -$217K 63
2022
Q4
$217K Buy
+423
New +$215K 0.22% 57

Other funds holding ELV

Bay Rivers Group's ELV Position: Q4 2024 in Review

Bay Rivers Group sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 395 shares — an estimated $205K sold.

Bay Rivers Group first reported a position in ELV in Q4 2022 and held it in 4 quarters. The position peaked at $217K in Q4 2022. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Bay Rivers Group reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Bay Rivers Group sold 395 Elevance Health shares in Q4 2024, an estimated $205K.
  • Bay Rivers Group first reported a position in Elevance Health in Q4 2022 and held it in 4 quarters.
  • Bay Rivers Group's Elevance Health position peaked at $217K in Q4 2022.
  • 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Bay Rivers Group's 13F filing for Q4 2024, filed 22 Jan 2025.